Strategy

A Big Pharma deal that shares risk and reward

Read more

Focus on ophthalmology: new treatment modality

Read more

Due diligence is more than a numbers game

Read more

Kymab unlocks the power of the mouse

Read more

The role of technology providers in biotech

Read more

Risk sharing with Pharma -- is this the way to go?

Read more

Partnering with Russia

Read more

Cellzome secures a lead in drug discovery

Read more

Innate Pharma's anti-cancer platform attracts BMS investment

Read more

Virtual drug development at Eli Lilly

Read more